Bioethics Valuation
| BOTH Stock | USD 0.01 0.00 0.00% |
Bioethics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Bioethics from analyzing the firm fundamentals such as Price To Book of 2,021 X, return on asset of -56.39, and Shares Outstanding of 1.14 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bioethics' price fluctuation is out of control at this time. Calculation of the real value of Bioethics is based on 3 months time horizon. Increasing Bioethics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bioethics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioethics Pink Sheet. However, Bioethics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0051 | Real 0.004896 | Hype 0.007077 |
The intrinsic value of Bioethics' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Bioethics' stock price.
Estimating the potential upside or downside of Bioethics helps investors to forecast how Bioethics pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioethics more accurately as focusing exclusively on Bioethics' fundamentals will not take into account other important factors: Bioethics Total Value Analysis
Bioethics is currently anticipated to have valuation of 647.72 K with market capitalization of 295.15 K, debt of 398.53 K, and cash on hands of 554. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Bioethics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
647.72 K | 295.15 K | 398.53 K | 554 |
Bioethics Asset Utilization
One of the ways to look at asset utilization of Bioethics is to check how much profit was generated for every dollar of assets it reports. Bioethics shows a negative utilization of assets of -56.39 percent, losing $0.56 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Bioethics shows how discouraging it operates for each dollar spent on its assets.Bioethics Ownership Allocation
Bioethics shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.53 percent of Bioethics outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event.Bioethics Profitability Analysis
Net Loss for the year was (107.18 K) with profit before overhead, payroll, taxes, and interest of 0.About Bioethics Valuation
An absolute valuation paradigm, as applied to Bioethics Pink Sheet, attempts to find the value of Bioethics based on its fundamental and basic technical indicators. By analyzing Bioethics's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bioethics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bioethics. We calculate exposure to Bioethics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioethics's related companies.It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States.
8 Steps to conduct Bioethics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bioethics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bioethics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bioethics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bioethics' revenue streams: Identify Bioethics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bioethics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bioethics' growth potential: Evaluate Bioethics' management, business model, and growth potential.
- Determine Bioethics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bioethics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Bioethics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.1 M | |
| Retained Earnings | -1.1 M |
Complementary Tools for Bioethics Pink Sheet analysis
When running Bioethics' price analysis, check to measure Bioethics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioethics is operating at the current time. Most of Bioethics' value examination focuses on studying past and present price action to predict the probability of Bioethics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioethics' price. Additionally, you may evaluate how the addition of Bioethics to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges |